Abstract:Although the importance of circulating tumor cells (CTCs) has been widely recognized, it is still a challenge to realize high-efficiency and accurate enrichment and identification of highly heterogeneous CTCs derived from various types of tumors in complex cancer processes. Currently, the most widely used methods follow the general idea of sequential immunoaffinitive capture and immunostaining to achieve the abovementioned goal. However, different organ/tissue origins as well as the inherent heterogeneity of CTCs would lead to the missed detection of certain CTC subtypes using such methods. Further, immunocytochemistry (ICC) immunostaining disrupts the physiological structure of cells, severely limiting the detection and application scenarios that require the participation of live cells. To address these limitations, we have developed a generally applicable strategy for the isolation and labeling of CTCs. This strategy focuses on targeting the universal characteristics of all tumor cells, specifically the abnormally expressed cell membrane glycoproteins, such as the transferrin receptor and sialic acid. Strategically, transferrin-functionalized magnetic beads (TMBs) were applied to enrich CTCs, and azide-based bioorthogonal chemistry was employed to label target CTCs. Accordingly, the membrane glycoprotein-targeting strategy achieved unbiased enrichment and labeling of broad-spectrum CTCs that were both epithelial and non-epithelial phenotypic populations with varied organ/tissue origins (MCF-7, HepG2, A549, Jurkat, and B16), with a capture efficiency of >95% and a detection limit as low as 5 cells per mL in artificial blood. In particular, our developed strategy displayed excellent specificity, and the CTCs under capture and fluorescence labelling remained with good viability and could be further cultivated and analyzed. Finally, the membrane glycoprotein-targeting strategy successfully detected and identified 33-223 CTCs from 1 mL patient blood samples.

Hybrid Extracellular Vesicles‐Liposomes Camouflaged Magnetic Vesicles Cooperating with Bioorthogonal Click Chemistry for High‐Efficient Melanoma Circulating Tumor Cells Enrichment

Cell-Released Magnetic Vesicles Capturing Metabolic Labeled Rare Circulating Tumor Cells Based on Bioorthogonal Chemistry

Greatly isolated heterogeneous circulating tumor cells using hybrid engineered cell membrane-camouflaged magnetic nanoparticles

Multi-targeting magnetic hyaluronan capsules efficiently capturing circulating tumor cells.

Generally Applicable Circulating Tumor Cell Enrichment and Identification Through a Membrane Glycoprotein-Targeting Strategy Combining Magnetic Isolation and Biological Orthogonality Labeling.

Cancer-leukocyte Hybrid Membrane-Cloaked Magnetic Beads for the Ultrasensitive Isolation, Purification, and Non-Destructive Release of Circulating Tumor Cells.

General Applicable Circulating Tumor Cell Enrichment and Identification Through the Membrane Glycoprotein-targeted Strategy Combining Magnetic Isolation and Biological Orthogonality Labeling

Enhanced and High-Purity Enrichment of Circulating Tumor Cells Based on Immunomagnetic Nanospheres

Engineered Red Blood Cells For Capturing Circulating Tumor Cells With High Performance

Biotin-triggered Decomposable Immunomagnetic Beads for Capture and Release of Circulating Tumor Cells.

Multi-Marker Immunomagnetic Enrichment of Circulating Melanoma Cells

Genetically Engineered Cell Membrane‐Coated Magnetic Nanoparticles for High‐Performance Isolation of Circulating Tumor Cells

Combining hybrid cell membrane modified magnetic nanoparticles and inverted microfluidic chip for in situ CTCs capture and inactivation

Gradient Magnetic Separation and Fluorescent Imaging‐Based Heterogeneous Circulating Tumor Cell Subpopulations Assay with Biomimetic Multifunctional Nanoprobes

Artificial cell membrane camouflaged immunomagnetic nanoparticles for enhanced circulating tumor cell isolation

Magnetic Particles Assisted Capture and Release of Rare Circulating Tumor Cells Using Wavy-Herringbone Structured Microfluidic Devices.

Effective Isolation, Label and Release of Multitype Circulating Tumor Cells Base on CdSe/ZnS Quantum Dots and Dual-antibody Modified Magnetic Nanoparticles

Effective Capture and Release of Circulating Tumor Cells Using Core-Shell Fe 3 O 4 @mno 2 Nanoparticles

Leukocyte-Repelling Biomimetic Immunomagnetic Nanoplatform for High-Performance Circulating Tumor Cells Isolation.

Β-Cyclodextrin Coated and Folic Acid Conjugated Magnetic Halloysite Nanotubes for Targeting and Isolating of Cancer Cells.

Polyethylene Glycol-Functionalized Magnetic Fe3O4/P(MMA-AA) Composite Nanoparticles Enhancing Efficient Capture of Circulating Tumor Cells